Genocea Biosciences, Inc.
GNCA
GNCA was delisted on the 2nd of June, 2022.
70 hedge funds and large institutions have $118M invested in Genocea Biosciences, Inc. in 2015 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 34 increasing their positions, 14 reducing their positions, and 2 closing their positions.
500% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 2
143% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 14
17% more funds holding
Funds holding: 60 → 70 (+10)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
35% less capital invested
Capital invested by funds: $182M → $118M (-$63.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$8.06M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.27M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
+$6.95M |
| 4 |
AIC
AWM Investment Company
New York
|
+$6.1M |
| 5 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
+$4.96M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$6.59M |
| 2 |
DM
Deerfield Management
New York
|
-$781K |
| 3 |
GTC
Ghost Tree Capital
New York
|
-$620K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$481K |
| 5 |
Renaissance Technologies
New York
|
-$314K |
GNCA Hedge Fund Activity: Q3 2015 in Review
70 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Genocea Biosciences, Inc. (GNCA) for Q3 2015, worth a combined $118M — down 35% from $182M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new GNCA positions and 2 closed out — a net gain of 10 holders — while 34 added to existing stakes and 14 trimmed.
The largest buyer was Rock Springs Capital Management, opening a new position worth an estimated $8.06M. The largest seller was Redmile Group, cutting an estimated $6.59M.
- 70 institutional investors held Genocea Biosciences, Inc. (GNCA) as of Q3 2015, up from 60 in Q2 2015.
- Funds reported $118M of Genocea Biosciences, Inc. stock for Q3 2015, down 35% quarter-over-quarter.
- 12 funds opened new Genocea Biosciences, Inc. positions in Q3 2015 and 2 closed out, a net change of +10 holders.
- The largest Genocea Biosciences, Inc. buyer in Q3 2015 was Rock Springs Capital Management, an estimated $8.06M added.
- The largest Genocea Biosciences, Inc. seller in Q3 2015 was Redmile Group, an estimated $6.59M sold.
Based on aggregated 13F filings for Q3 2015.